Sørensen P G, Ernst P, Panduro J, Møller J
Scand J Haematol. 1984 Mar;32(3):253-7. doi: 10.1111/j.1600-0609.1984.tb01689.x.
20 patients with leukaemia in remission or early relapse received an allogeneic bone marrow graft. Patients were conditioned according to Seattle protocol with high dose cyclophosphamide and total body irradiation to a total dose of 8 Gray to the lungs delivered by a 6 MV linear accelerator at a dose rate of approximately 0.06 Gray/min. As prophylaxis against the graft versus host reaction, methotrexate and/or cyclosporin A were given. Lung function was studied prior to treatment and every 3 months thereafter. Before treatment a marked decrease was seen in the CO diffusion capacity when compared to the predicted value, while the flow volume relationships were within normal limits. The cause of this is unknown, but may be due to previous infections and the cytostatic treatment given. After bone marrow transplantation, a further irreversible decrease was seen in the CO diffusion capacity and vital capacity indicating an additive effect of the lung irradiation.
20例处于缓解期或早期复发的白血病患者接受了异基因骨髓移植。患者按照西雅图方案进行预处理,使用大剂量环磷酰胺和全身照射,通过6兆伏直线加速器以约0.06戈瑞/分钟的剂量率向肺部输送总计8戈瑞的辐射剂量。作为预防移植物抗宿主反应的措施,给予了甲氨蝶呤和/或环孢素A。在治疗前及之后每3个月对肺功能进行研究。治疗前,与预测值相比,一氧化碳弥散能力显著下降,而流量-容积关系在正常范围内。其原因尚不清楚,但可能与既往感染及所给予的细胞毒性治疗有关。骨髓移植后,一氧化碳弥散能力和肺活量进一步出现不可逆下降,表明肺部照射具有叠加效应。